Kaempferia rotunda (Kaempferia rotunda): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Kaempferia rotunda work for pain relief?

Kaempferia rotunda exerts analgesic and anti-inflammatory effects primarily through its flavonoid content, particularly kaempferol, which inhibits pro-inflammatory cytokines and cyclooxygenase (COX) pathways. The essential oils and crotepoxide contribute additional anti-inflammatory activity. Research suggests these compounds modulate inflammatory mediators, reducing pain signaling and swelling. Evidence level C indicates promising but preliminary data, with traditional use supporting these mechanisms for wound healing and pain management.

Does Kaempferia rotunda interact with any medications?

Limited clinical data exists on drug interactions for Kaempferia rotunda. However, due to its anti-inflammatory properties and flavonoid content, it may theoretically potentiate the effects of anticoagulant or antiplatelet medications. Patients taking blood thinners, NSAIDs, or immunosuppressants should consult a healthcare provider before use. The lack of robust interaction studies (Evidence level C) warrants caution when combining with prescription medications.

What is the recommended dosage for Kaempferia rotunda?

Traditional Ayurvedic and Thai medicine preparations typically use 3-5 grams of dried rhizome as a decoction, taken twice daily. For topical applications, a paste made from the fresh or dried rhizome is applied directly to wounds or inflamed areas. Standardized extracts are not widely available, so dosing follows traditional preparation methods. Evidence level C supports these traditional dosages, though clinical trials establishing optimal therapeutic doses are lacking.

Is Kaempferia rotunda safe during pregnancy and breastfeeding?

Kaempferia rotunda is contraindicated during pregnancy and should be avoided. Traditional use and available evidence indicate potential uterine stimulant effects, making it unsafe for pregnant women. There is insufficient data on safety during breastfeeding, so avoidance is recommended. Women of childbearing age should use reliable contraception when taking this herb internally. Always consult a qualified healthcare provider before using any herbal remedy during pregnancy.

What are the traditional uses of Kaempferia rotunda?

Kaempferia rotunda has been used for centuries in Ayurvedic and Thai traditional medicine primarily for treating wounds, reducing inflammation, and managing pain. The rhizome is applied topically for skin conditions, swelling, and wound healing, while internal preparations address fever and digestive complaints. Traditional practitioners value it for its antimicrobial and analgesic properties. Evidence level C supports these traditional applications, though more rigorous clinical studies are needed.

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 17 articles PubMed · modèle : gemma4:31b

Résumé

Kaempferia rotunda is a plant of the ginger family (Zingiberaceae) with documented antioxidant, antiplatelet, and anticancer properties in vitro and in vivo [PMID:20046746, 31505204, 17913483].

Contexte

Kaempferia rotunda Linn. is a member of the Zingiberaceae family [PMID:31505204, 34814832]. It is characterized by tuberous rhizomes [PMID:31505204, 19137858].

Usages traditionnels

The plant has been used as food and as a traditional medicinal plant, including applications as antimicrobial and anticancer agents [PMID:24449374, 31505204].

Composés actifs

Identified constituents include flavonoids, phenolic derivatives [PMID:20046746], 2'-hydroxy-4,4',6'-trimethoxy-chalcone [PMID:19137858], (+)-crotepoxide [PMID:19137858], 3-deacetylcrotepoxide [PMID:17913483, 21589115], and various polyoxygenated cyclohexane derivatives [PMID:25111413, 17493646]. It also contains tuberous rhizome lectins (KRL) [PMID:31505204, 21707523].

Mécanisme d'action

Anticancer activity is mediated through the induction of apoptosis, cell cycle arrest (G0/G1 or G2/M), and modulation of proteins including PARP1, p53, p21, Bax, Bcl2, caspase-3, and caspase-9 [PMID:31505204, 24449374]. It exhibits antioxidant effects by controlling lipid peroxidation markers such as malonaldehyde (MDA) and 4-hydroxyl-2-nonenal (4-HNE) [PMID:20046746] and scavenging DPPH free radicals [PMID:19137858]. Certain compounds act as platelet-activating factor (PAF) receptor binding inhibitors [PMID:15742349] and inhibit arachidonic acid-induced platelet aggregation [PMID:17913483].

Preuves cliniques

Preuve DColon Cancer (in vitro)

Tuberous rhizome lectin (KRL) inhibited growth of SW480 (67%) and SW48 (59%) cells at 1.0 mg/ml [PMID:31505204]

Preuve DEhrlich Ascites Carcinoma (in vitro/in vivo)

KRL inhibited cell growth (6.2-50.5%) in vitro [PMID:24449374]; a 21kDa lectin showed 43.7% growth inhibition in vitro at 160µg/ml [PMID:28461165].

Preuve DHepatocellular and Lung Cancer (in vitro)

K. rotunda-mediated silver/silver chloride nanoparticles inhibited A549 (IC50 59.7 µg/ml) and SMMC-7721 (IC50 126.3 µg/ml) cell lines [PMID:39290346]

Preuve DGlioblastoma Stem Cells (in vitro)

K. rotunda-mediated Ag/AgCl-NPs inhibited 77.2% of GSCs growth at 32 µg/mL (IC50 6.8 µg/mL) [PMID:33047886]

Preuve DPancreatic and Breast Cancer (in vitro)

Compound 12 from methanolic extract showed moderate cytotoxic activity against PSN-1 and MDA-MB231 lines [PMID:25111413]

Synthèse des preuves

The current evidence consists primarily of in vitro laboratory studies and animal models (Level D), demonstrating significant potential for antioxidant, antiplatelet, and antitumor activities, particularly through the use of isolated lectins and synthesized nanoparticles.

Sources PubMed

1.PMID: 37765107 (2023) — Anti-Aging Potential of Plants of the Anak Dalam Tribe, Jambi, Indonesia. · Pharmaceuticals (Basel, Switzerland)
2.PMID: 20046746 (2008) — Evaluation of Antioxidant Potential of Kaempferia rotunda Linn. · Indian journal of pharmaceutical sciences
3.PMID: 39290346 (2024) — Asparagus racemosus silver chloride nanoparticles and Kaempferia rotunda mediated silver/silver chloride nanoparticles inhibit human hepatocellular and lung cancer cell lines. · Biochemistry and biophysics reports
4.PMID: 34814832 (2021) — Molecular evolution of chloroplast genomes in subfamily Zingiberoideae (Zingiberaceae). · BMC plant biology
5.PMID: 31505204 (2019) — Kaempferia rotunda tuberous rhizome lectin induces apoptosis and growth inhibition of colon cancer cells in vitro.

Kaempferia rotunda

Sources et citations

Calculer une dose sûre de Kaempferia rotunda

Ixora coccinea

Trichilia Havanensis

Psidium Guineense

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Synthèse des preuves

Sources PubMed

Sources gouvernementales

Kaempferia rotunda

Sources et citations

Calculer une dose sûre de Kaempferia rotunda

Plantes associées

Ixora coccinea

Trichilia Havanensis

Psidium Guineense

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Synthèse des preuves

Sources PubMed

Sources gouvernementales